CVS Health Beats Q3 Estimates, Raises Guidance
The healthcare company reported third-quarter 2026 results above Wall Street projections and lifted its full-year outlook.
Updated on Nov. 4, 2026 in Healthcare
Live Poll
Do you think prescription drug costs are getting better or worse for you?
CVS Health posted third-quarter adjusted earnings per share of $2.09, above Wall Street's consensus projection of $1.65, on revenue of $108.4 billion for the three months ended September 30. The company also raised its full-year 2026 adjusted EPS guidance to at least $8.20.
Why it matters
The results reflect continued execution of the company's margin recovery plan, with adjusted operating income improving in the Health Care Benefits segment. For U.S. readers, the performance offers a view into the financial health of a major health insurer and pharmacy operator.
Operating income reached $3.6 billion, compared with an operating loss of $3.2 billion a year earlier that included a $5.7 billion goodwill impairment charge. The Health Care Benefits medical benefit ratio fell to 91.3% from 92.8%, though the extraction does not detail the drivers beyond government business performance.
The players
CVS Health
CVS Health is a large U.S. healthcare company operating pharmacy, health insurance, and care delivery businesses, headquartered in Woonsocket, Rhode Island.
The details
CVS Health raised its GAAP diluted EPS guidance to at least $6.98 and its cash flow from operations projection to at least $15.5 billion. Total revenues rose 5.4% year over year, and medical membership stood at 26.1 million at quarter's end.
Timeline
September 30, 2026: Third-quarter results reported
September 2025: Omnicare, LLC was deconsolidated
Third quarter of 2025: Rite Aid asset acquisitions completed
2026: Individual exchange business exited
Margin Recovery
The quarter's swing from a $3.2 billion operating loss to $3.6 billion in operating income follows the absence of the $5.7 billion goodwill impairment recorded against the Health Care Delivery unit in the prior-year period. The adjusted operating income gain of 21.2% indicates the company's margin recovery plan is carrying forward past that writedown.
Raised guidance and improved medical cost performance may influence the pricing and coverage decisions of health plans that rely on CVS Health's Aetna and pharmacy services. Customers of its pharmacy and insurance products are unlikely to see immediate changes from the quarterly results alone.
The takeaway
Strong quarterly results paired with raised guidance signal that CVS Health's recovery is taking hold, though investors and customers should track whether margin gains hold through the coming year.
Further reading
Track more coverage in Healthcare for context on insurer and pharmacy earnings trends.
Source note: This article includes information reported by Mass Market Retailers.
Live Poll
Do you think prescription drug costs are getting better or worse for you?
